m-CTG: A low cost mobile-phone cardiotocograph device for antenatal and intrapartum monitoring to prevent perinatal mortality in low resource settings

Grand Challenges Canada0 个研究点目标入组 910 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•Inclusion criteria
•1. Group 1: Pregnant women admitted for delivery
•1.1. Inclusion criteria
•1.1.1 Age: >18 years Ã¢â?¬â?? 45 years
•1.1.2 Parity: any
•1.1.3 Gestation age: 37 weeks to 41 weeks
•1.1.4 Fetus: Singleton
•1.1.5 Risk status: low risk
•1.1.6 Labour status: in active labour in first stage of labour of spontaneous onset
•2. Group 2. Pregnant women with high risk factors in third trimester
•2.1 Inclusion criteria
•2.1.1 Age: >18 years Ã¢â?¬â?? 45 years
•2.1.2 Parity: any
•2.1.3 Gestation age: Ã¢â?°Â¥ 32 weeks
•2.1.4 Fetus: Singleton
•2.1.5 Labour status: not in active labour

•Exclusion criteria
•1. Group 1: Pregnant women admitted for delivery
•1.2.1 Women with age outside the range
•1.2.2. Women with gestation status outside the range
•1.2.3 Women with high risk factors (hypertension, IUGR, oligohydramnios, gestational diabetes, known fetal malformations, multiple gestations)
•1.2.4 Women with a medical/systemic disease (cardiac, neurological, respiratory any other systemic disease other than those listed in high risk obstetric condition)
•1.2.5 Women with induced labour
•1.2.6 Women on drugs at the time of screening/ taken in last 24 hours (tocolytic drugs)
•1.2.7 Not given written informed consent
•2. Group 2. Pregnant women with high risk factors in third trimester
•2.2 Exclusion criteria
•2.2.1 Women with age outside the range
•2.2.2 Women with gestation status outside the range
•2.2.3 Women in active labour
•2.2.4 Women taken any tocolytic drug in last 24 hours
•2.2.5 Not given written informed consent

发起方